Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.76B |
| 2 |
Tesla
TSLA
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$623M |
| 4 |
AbbVie
ABBV
|
+$398M |
| 5 |
Qualcomm
QCOM
|
+$394M |
Top Sells
| 1 |
CELG
Celgene Corp
CELG
|
+$1.54B |
| 2 |
Johnson & Johnson
JNJ
|
+$603M |
| 3 |
Micron Technology
MU
|
+$366M |
| 4 |
Meta Platforms (Facebook)
META
|
+$365M |
| 5 |
UnitedHealth
UNH
|
+$353M |
Sector Composition
| 1 | Healthcare | 21.21% |
| 2 | Technology | 12.91% |
| 3 | Consumer Discretionary | 10.45% |
| 4 | Financials | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2976
Performance Shipping
PSHG
$24.1M
| $399K | ﹤0.01% |
3,165
+1,831
| +137% | +$231K |
|
|
LITB
2977
LightInTheBox
LITB
$32.9M
| $396K | ﹤0.01% |
62,872
+948
| +2% | +$5.97K |
|
|
COWN
2978
DELISTED
Cowen Inc. Class A Common Stock
COWN
| $395K | ﹤0.01% |
25,050
-52,328
| -68% | -$825K |
|
2979
PACCAR
PCAR
$51.6B
| $394K | ﹤0.01% |
7,467
-517,050
| -99% | -$27.3M |
|
2980
Cardiff Oncology
CRDF
$137M
| $393K | ﹤0.01% |
317,303
+7,700
| +2% | +$9.54K |
|
2981
Quanterix
QTRX
$202M
| $392K | ﹤0.01% |
+16,600
| New | +$392K |
|
2982
Bel Fuse Class A
BELFA
$1.49B
| $389K | ﹤0.01% |
24,000
+1,800
| +8% | +$29.2K |
|
2983
Noodles & Co
NDLS
$30.5M
| $387K | ﹤0.01% |
+69,785
| New | +$387K |
|
|
JCAP
2984
DELISTED
Jernigan Capital, Inc.
JCAP
| $387K | ﹤0.01% |
20,200
-174,812
| -90% | -$3.35M |
|
2985
Global X SuperDividend US ETF
DIV
$644M
| $384K | ﹤0.01% |
+16,187
| New | +$384K |
|
|
EMX
2986
EMX Royalty
EMX
$442M
| $384K | ﹤0.01% |
233,632
+17,130
| +8% | +$28.2K |
|
2987
Soleno Therapeutics
SLNO
$3.19B
| $384K | ﹤0.01% |
8,717
-1,708
| -16% | -$75.2K |
|
|
GNMX
2988
DELISTED
Aevi Genomic Medicine, Inc.
GNMX
| $382K | ﹤0.01% |
2,615,632
+223,844
| +9% | +$32.7K |
|
|
CART
2989
DELISTED
Carolina Trust BancShares
CART
| $381K | ﹤0.01% |
29,200
+1,700
| +6% | +$22.2K |
|
2990
ProPhase Labs
PRPH
$19.8M
| $379K | ﹤0.01% |
192,600
+1,000
| +0.5% | +$1.97K |
|
2991
Cemtrex
CETX
$4.57M
| $378K | ﹤0.01% |
4
+1
| +33% | +$94.5K |
|
2992
ProShares UltraPro S&P 500
UPRO
$4.6B
| $378K | ﹤0.01% |
+10,800
| New | +$378K |
|
2993
Vanguard Small-Cap Growth ETF
VBK
$20.3B
| $378K | ﹤0.01% |
1,900
+800
| +73% | +$159K |
|
2994
Auburn National Bancorp
AUBN
$85.6M
| $376K | ﹤0.01% |
7,090
+690
| +11% | +$36.6K |
|
2995
Celcuity
CELC
$2.43B
| $376K | ﹤0.01% |
+35,300
| New | +$376K |
|
2996
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$3.79B
| $376K | ﹤0.01% |
19,000
-6,000
| -24% | -$119K |
|
|
PBBI
2997
DELISTED
PB Bancorp, Inc. Common Stock
PBBI
| $376K | ﹤0.01% |
+24,800
| New | +$376K |
|
2998
Galmed Pharmaceuticals
GLMD
$7.67M
| $375K | ﹤0.01% |
361
+269
| +292% | +$279K |
|
2999
Tonix Pharmaceuticals
TNXP
$230M
| $375K | ﹤0.01% |
+1
| New | +$375K |
|
3000
iShares Core 80/20 Aggressive Allocation ETF
AOA
$2.55B
| $374K | ﹤0.01% |
+6,456
| New | +$374K |
|